Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Calcium Physiology |Magnesium Physiology |Calcitonin |Hypocalcaemia |Hypercalcaemia |Hypomagnesaemia |Hypermagnesaemia |Primary Hyperparathyroidism |Familial hypocalciuric hypercalcaemia (FHH) |Sarcoidosis
⚠️ Caution: For peripheral administration, magnesium sulfate 50% must be diluted to ≤5% (20 mmol in 100 mL) to avoid pain, thrombophlebitis, or tissue necrosis. Use central access if higher concentrations are required.
| Indication | Dose | Infusion Rate | Comments |
|---|---|---|---|
| Torsades de Pointes | 8 mmol (2 g) IV | Over 10–15 min in 100 mL 5% Dextrose / NaCl | Then 72 mmol (18 g) / 24 h infusion if recurrent. |
| Acute Severe Asthma | 8 mmol (2 g) IV | Over 20 min | Single dose; improves FEV₁ and reduces admission risk. |
| Eclampsia | 16 mmol (4 g) loading → 96–192 mmol (12–24 g) / 24 h | Loading over 20 min; maintenance infusion 1 g / h | Use Pritchard or Zuspan regimens; monitor reflexes, RR, and urine output. |
| Hypomagnesaemia | 20 mmol (5 g) | Over 1–3 h | Max 50 mmol / day; up to 160 mmol over 5 days if persistent deficiency. |